CABB Group to Sell Jayhawk Fine Chemicals to Anupam Rasayan

CABB Group has signed a definitive agreement with Anupam Rasayan to sell a 100% equity stake in its US-based production site, Jayhawk Fine Chemicals, for approximately $150 million.

The sale of Jayhawk Fine Chemicals marks a key step in CABB’s shift away from industrial and electronics applications toward higher-margin pharma and life science specialties produced at its European sites, while supporting Anupam Rasayan’s US expansion and long-term growth plans for Jayhawk.

Tobias Schalow, CEO, CABB Group, stated: “This transaction marks a strategic step for our company, and we have made this decision with the utmost confidence and trust in the new owner. We have developed a scalable growth platform in Pharma and Life Science specialties, which we will further develop and expand, and shift away from industrial applications, electronics, and semiconductors with this transaction. We are certain that Anupam Rasayan is perfectly positioned for long-term growth with the Jayhawk team, and we wish them success as they embark on this new chapter. On behalf of the CABB Group, I would like to express my deepest gratitude to the dedicated and highly skilled team at Jayhawk. Their commitment over the past years has been a cornerstone of our success.”

Anand Desai, Managing Director, Anupam Rasayan, said, “This acquisition is a transformative step in Anupam’s global journey. Jayhawk brings to us a legacy of innovation, deep customer relationships, and a strong technology platform in high-value chemistries. Together, we will leverage our complementary strengths to accelerate growth, enhance our global presence, and deliver greater value to customers across key sectors such as performance materials, aerospace, and electronics. Now, with Jayhawk, we move forward in the value chain, closer to the end applications, manufacturing key N-1 molecules for critical sectors such as electronics, semiconductors, and performance materials. The addition of Jayhawk’s U.S. operations significantly strengthens our global footprint and positions us closer to strategic customers in developed markets.”

The Jayhawk site was previously owned by Evonik before being sold to Permira in 2018 and brought under CABB’s ownership. This latest transaction will see Jayhawk change hands again, with Anupam Rasayan now set to acquire the site from CABB.

Anupam Rasayan is one of the leading companies engaged in the custom synthesis and manufacturing of specialty chemicals in India. Incorporated in 1984, the specialty chemicals major has two verticals: Life sciences-related specialty chemicals comprising products for applications in agrochemicals, personal care and pharmaceuticals, and Other Specialty Chemicals comprising specialty pigments and dyes, and polymer additives. Anupam Rasayan caters to a diverse base of Indian and global customers. The company operates via its six manufacturing facilities in Gujarat, India, with four facilities located at Sachin, Surat and two located at Jhagadia, Bharuch.